Heart failure drug shows promise in extended safety trial
Disease control
Completed
This study looked at the safety of a drug called levosimendan when used for a longer time in people who have both pulmonary hypertension and a type of heart failure where the heart pumps normally but is stiff (HFpEF). 35 patients who had already been in a previous study received …
Phase: PHASE2 • Sponsor: Tenax Therapeutics, Inc. • Aim: Disease control
Last updated May 13, 2026 15:59 UTC